Radiopharmaceutical Scientist

Summary

We are seeking a motivated Radiochemist to join our Radiochemistry & CMC Development team in Oslo. This is a temporary position (contract), with the possibility for extension or transition to a permanent role.

You will support radiochemistry method development, contribute to analytical characterization, and help advance our pipeline of targeted alpha therapies. The role is lab-based and suitable for both junior candidates starting their career and more experienced radiochemists looking to broaden their CMC expertise.

Responsibilities

• Perform radiolabelling of peptides, antibodies, and small molecules with therapeutic and diagnostic radionuclides (e.g., Pb-212, Pb-203, Ga-68) both manually and automated.
• Support analytical method development and QC testing (radio-HPLC, iTLC, gamma spectroscopy, stability studies).
• Contribute to CMC documentation (protocols, batch records, reports, validation activities).
• Assist with process optimization to improve yield, purity, and specific activity.
• Collaborate across functions (Discovery, CMC, TechOps) to support program deliverables.
• Maintain accurate records and adhere to all radiation safety and laboratory procedures.

Qualifications & Education

Personal Attributes

What We Offer

About Us

ARTBIO is a clinical-stage radiopharmaceutical company redefining cancer care by creating a new class of alpha radioligand therapies (ARTs). The unique ARTBIO approach selects the optimal alpha-precursor isotope (212Pb) and tumor-specific targets to create therapeutics with the potential for highest efficacy and safety. The company’s AlphaDirect technology, a first-of-its-kind 212Pb isolation method, enables a distributed manufacturing approach for the reliable production and delivery of ARTs. ARTBIO is advancing multiple pipeline programs with lead program AB001 currently in first in human trials. ARTBIO is shaped by a long-standing scientific legacy with nearly a century of pioneering work in radiation therapy conducted at the University of Oslo and Norway’s Radium Hospital. For more information, visit and follow us on LinkedIn and Twitter.

As an emerging, global biotech with locations in Boston, Massachusetts, Basel, Switzerland, London, England and Oslo, Norway, we take advantage of diverse scientific depth and insights which makes ARTBIO a unique place to work. We are driven by a desire to do better for cancer patients, lowering the burden of toleration and safety while at the same time raising the bar on clinical efficacy and duration.

EEO Statement

ARTBIO is proud to be an equal opportunity workplace and is an affirmative action employer. We are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status. If you have a disability or special need that requires accommodation, please let us know.

ARTBIO does not accept unsolicited resumes from external agencies or recruiters. Submission of a resume without a prior written agreement does not create any express or implied contract between ARTBIO and the agency. ARTBIO will not pay any fees related to unsolicited resumes.

#J-18808-Ljbffr